Skip to main content

Closed

IMCR: Immunocore Holdings plc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-0.7% / yr

Operating margin-7.6%

ROIC-3.5%

Financially safe

Stretched

Debt / equity1.11×

Interest coverage-2.6×

Current ratio4.18×

Immunocore Holdings plc

IMCRNASDAQ Global Select·USD·Closed

Immunocore Holdings plc

IMCRNASDAQ·USD·Closed

$33.81

−0.18%

$33.81

−$0.06 (0.18%)

52W Range

48thpctl

Volume

1.50×avg

Mkt Cap

1.72BUSD

P/E

-90.3TTM

Div Yield

–ann

52W Range

48thpctl

Volume

1.50×avg

Market Cap

1.72BUSD

P/E Ratio

-90.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings